Hiroshi Miyake

Chief Executive Officer

Fujisawa, Japan

Hiroshi Miyake, Ph.D., co-founded Chordia Therapeutics in November 2017 and has served as President, CEO, and a board member since incorporation. He previously led the oncology drug discovery unit at Takeda Pharmaceutical. He holds a B.S. from Osaka University and a Ph.D. in Pharmacology from the University of Tokyo.

Expertise

• Oncology
• Drug Discovery
• Biotechnology